Biopharmaceutical company Immunic, Inc. recently announced the appointment of experienced industry executive Jon Congleton to its board of directors.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Banxico: Flexible stance with upside risks – Rabobank
Planet Ventures CEO Etienne Moshevich resigns
India Relaxes Asset Management Rules: Portfolio Management Industry Approved for Overseas Investment and Short Selling Stocks for the First Time
Indian regulators announced on Thursday that they will allow the country’s $463 billion portfolio management industry to invest in overseas securities for the first time and to conduct short-selling in stock options. This move opens up new channels for India’s wealthy class to access global markets and holds significance for AI-related assets, which have attracted strong investor interest. Additionally, India will launch new portfolio management products with lower investment thresholds.
Waldencast Files to Delist Shares, Warrants From Nasdaq
Crypto prices
More
